Business
Press Release Aug 01 2023
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 01, 2023, titled "Glenmark Pharmaceuticals receives ANDA approval for Saxagliptin Tablets,2.5 mg and 5 mg".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 01, 2023, titled \"Glenmark Pharmaceuticals receives ANDA approval for Saxagliptin Tablets,2.5 mg and 5 mg\". View Attachment","length":357,"tagName":"div"}]